Alacrity Medical Innovations

About

Alacrity Medical Innovations

Office Location

Alacrity Medical Innovations (AMI) seeks to transform the treatment of life-interrupting bleeding, initially for patients on anticoagulant medications (“blood thinners”) and ultimately for a broader population. We are developing novel, convenient devices for anti-coagulated patients to stop life-interrupting bleeding events at home. Alacrity Medical Innovations’ (AMI) first product is a patent-pending, novel, easy-to-use drug delivery device in combination with a unique indication for an anti-fibrinolytic (“blood clot stabilizer”). Our device will simultaneously absorb blood while delivering the anti-fibrinolytic directly to wounds to stop life-interrupting bleeding in anti-coagulated patients.

Alacrity Medical Innovations
Alacrity Medical Innovations
Alacrity Medical Innovations

The Opportunity

Office Location

Anticoagulants

8-12 million patients estimated to be on anticoagulants (ACs).

  1. IBM Truven Health Analytics, 12 months ending December 31, 2018 for Commercial, Medicare and Medicaid patients (October 24, 2019).
  2. Agency for Healthcare Research and Quality. Number of people with purchase in thousands by therapeutic class, United States, 1996-2018. Medical Expenditure Panel Survey. Generated interactively: Sun May 16 2021.

Treatment Visits

2.8 million AC treatment visits in Q4 '14 (+38% vs Q2 '09).
Annualizes to >11 million visits in 2015.

Barnes G et al. National Trends in Ambulatory Oral Anticoagulant Use. Am J Med. 2015 December ; 128(12): 1300–1305.e2.

Alacrity Medical Innovations

The Solution

Office Location

Available by health-care provider prescription

Alacrity Medical Innovations

Medication

A topical formulation of well established anti-fibrinolytic drug.

Device

Hand-held device to apply direct pressure and administer the medication.

Alacrity Medical Innovations

Treatment

Stops bleeding in a clinical or home setting saving time and the potential need for an Emergency Room or Urgent Care visit.

Alacrity Medical Innovations

Proprietary Technology /
Expertise

Office Location

Alacrity Medical Innovations

Our Team

Office Location

Alacrity Medical Innovations

A. Travis Manasco, MD

Co-Founder, Chief Executive Officer
Alacrity Medical Innovations

Gavin Cook

Co-Founder, Chief Business Officer
Alacrity Medical Innovations

News Room

Office Location

Alacrity awarded $100,000 through the NCBC’s Small Business Research Loan Program (SRL)

Alacrity Medical Innovations was among the # of grants and loans totaling awarded by the North Carolina Biotechnology Center this past quarter.

Read More

Alacrity Medical Innovation CEO to present at Venture Connect 2021

Alacrity Medical Innovations is excited to announce that our CEO, Dr. A. Travis Manasco, will be presenting at Venture Connect 2021 Online Summit on Tuesday, March 23rd.

Read More